Parvoviruses PARV4/5 in hepatitis C virus-infected patient [4]

Emerging Infectious Diseases

Volumn 13, Issue 1, 2007, Pages 175-176

  Fryer, Jacqueline F ^a   Lucas, Sebastian B ^b   Padley, David ^a   Baylis, Sally A ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS; BLOOD SAMPLING; BOCAVIRUS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LETTER; LOWER RESPIRATORY TRACT INFECTION; NUCLEIC ACID AMPLIFICATION; OPEN READING FRAME; PARVOVIRUS; POLYMERASE CHAIN REACTION; VIRUS LOAD;

EID: 33846061251     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1301.060856     Document Type: Letter

References (10)

1. Tattersall P. The evolution of parvovirus taxomomy. In: Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR, editors. Parvoviruses. London: Hodder Arnold; 2006. p. 5-14.
2. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol. 2005;79:8230-6.
3. Allander T, Tammi MT, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A. 2005;102:12891-6.
4. Baylis SA, Shah N, Minor PD. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods. 2004;121:7-16.
5. Fryer JF, Kapoor A, Minor PD, Delwart E, Baylis SA. Novel parvovirus and related variant in human plasma. Emerg Infect Dis. 2006;12:151-4.
6. Padley DJ, Lucas SB, Saldanha J. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens. Transplantation. 2003;76:432-4.
7. Heegaard ED, Petersen BL, Heilman CL, Hornsleth A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol. 2002;40:933-6.
8. Flunker G, Peters A, Wiersbitzky S, Modrow S, Seidel W. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol (Berl). 1998;186:189-94.
9. Lefrere JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, et al. Persistent B19 infection in immuno-competent individuals: implications for transfusion safety. Blood. 2005;106:2890-5.
10. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, et al. Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A. 2006;103:7450-3.